VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
LearnAll lessons
Candlestick Patterns44 candles, each on two real charts
Pattern GuidesThe playbooks' setups on real breakouts
GlossaryInvesting terms in plain English
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
IRLA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
IRLAIRulya Therapeutics Inc.
$40.59$39M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksIRLAQuarterly Balance Sheet

IRulya Therapeutics Inc. (IRLA) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

IRulya Therapeutics Inc. (IRLA) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

IRLA Balance Sheet

Quarterly statement

IRLA Balance Sheet

IRulya Therapeutics Inc. (IRLA) balance sheet — 9-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets106.3M123.41M25.58M22.9M29.2M37.34M33.83M44.04M51.72M63.44M70.44M77.44M85.17M88.55M92.49M93.75M98.28M99.37M96.35M111.67M
Cash & Short-Term Investments105.24M115.98M18.16M17.75M26.29M34.71M31.6M40.78M47.85M59.45M67.82M75.06M83.22M87.56M90.2M90.18M94.34M94.66M91.52M106.8M
Cash Only39.82M115.98M18.16M5.81M6.45M16.83M7.77M6.21M2.67M7.89M21.81M20.75M21.63M22.65M46.71M44.58M31.81M46.93M67.56M69.72M
Short-Term Investments65.42M0011.94M19.84M17.88M23.83M34.57M45.17M51.55M46.01M54.31M61.59M64.92M43.49M45.6M62.53M47.74M23.96M37.08M
Accounts Receivable04.77M5.27M3.62M0992K916K882K995K964K971K993K500K0000000
Days Sales Outstanding--------------------
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets1.06M-4.77M1.31M54K1.09M55K32K84K55K79K48K81K141K405K1.33M2.37M2.31M3.58M4.09M3.39M
Total Non-Current Assets175K584K1.04M70.63M80.7M79.86M73.26M70.44M74.8M71.39M88.85M102.76M213K288K827K10.16M11.5M18.49M19.78M21.55M
Property, Plant & Equipment69K506K965K1.05M1.1M1.08M941K813K767K800K810K619K53K116K177K684K583K692K573K1.43M
Fixed Asset Turnover--------------------
Goodwill000000000017.25M17.63M00000825K00
Intangible Assets00067.82M67.73M67.57M62.36M60.05M64.53M61.79M62.25M63.67M0005.9M5.9M5.9M00
Long-Term Investments078K78K78K78K78K78K78K78K78K78K78K78K78K545K3.58M5M11.03M19.18M19.93M
Other Non-Current Assets106K001.68M11.8M11.14M9.88M9.51M9.43M8.72M8.47M8.47M82K94K105K3.58M17K47K29K194K
Total Assets106.47M124M26.62M93.52M109.9M117.21M107.09M114.48M126.52M134.83M159.29M180.2M85.39M88.84M93.32M103.91M109.78M117.86M116.13M133.23M
Asset Turnover--------------------
Asset Growth %-3.12%5.79%-75.14%-18.3%-13.14%-13.07%----70.7%73.42%-22.22%-24.63%-19.64%-22.01%-25.53%-26.97%-33.46%-29.68%
Total Current Liabilities7.22M8.5M8.77M43.23M26.04M7.47M8.36M7.28M5.42M10.32M9.84M9.57M2.25M1.95M3.12M3.07M4.95M5.95M9.71M14.22M
Accounts Payable1.45M4.64M5.39M2.22M3.4M1.76M3.01M2.9M1.62M2.4M2.07M2.03M409K353K1.65M570K1.18M1.87M3.73M4.91M
Days Payables Outstanding18.67K-9.52K--6.2K-13.01K---369.51--------
Short-Term Debt00113K18.03M17.52M00000064K00000000
Deferred Revenue (Current)00000000000000000000
Other Current Liabilities5.77M02.39M12.58M295K180K233K308K198K5.28M5.04M5.13M151K83K57K916K129K182K121K180K
Current Ratio14.72x14.52x2.92x0.53x1.12x5.00x4.05x6.05x9.53x6.15x7.16x8.09x37.80x45.36x29.69x30.55x19.87x16.70x9.92x7.85x
Quick Ratio14.72x14.52x2.92x0.53x1.12x5.00x4.05x6.05x9.53x6.15x7.16x8.09x37.80x45.36x29.69x30.55x19.87x16.70x9.92x7.85x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities21.15M7.01M2.18M86.01M82.8M98.01M80.15M77.05M76.16M77.54M75.28M85.55M000248K301K381K40K420K
Long-Term Debt0000016.99M15.27M14.32M14.9M13.83M13.52M13.43M00000000
Capital Lease Obligations00293K330K359K387K383K394K450K453K480K321K000053K133K40K420K
Deferred Tax Liabilities000109K5.59M5.59M5.17M4.96M5.38M5.17M5.18M17.61M000248K0000
Other Non-Current Liabilities21.15M7.01M1.89M85.68M76.84M75.04M59.33M57.38M55.43M58.08M56.1M54.19M0000248K248K00
Total Liabilities28.37M15.51M10.95M129.24M108.84M105.47M88.51M84.33M81.59M87.86M85.11M95.12M2.25M1.95M3.12M3.32M5.25M6.33M9.75M14.64M
Total Debt00406K18.47M17.99M17.49M15.75M14.81M15.45M14.38M14.09M13.81M61K147K269K453K420K524K339K1.16M
Net Debt-39.82M-115.98M-17.76M12.66M11.54M662K7.98M8.6M12.78M6.49M-7.72M-6.94M-21.57M-22.5M-46.45M-44.13M-31.39M-46.4M-67.22M-68.56M
Debt / Equity--0.03x-16.99x1.49x0.85x0.49x0.34x0.31x0.19x0.16x0.00x0.00x0.00x0.00x0.00x0.00x0.00x0.01x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage--------------------
Total Equity78.11M108.49M15.67M-35.71M1.06M11.74M18.58M30.15M44.93M46.97M74.18M85.08M83.13M86.88M90.2M100.59M104.53M111.53M106.38M118.59M
Equity Growth %7275.45%824.39%-15.66%-218.47%-97.64%-75.01%-----17.77%-15.42%-20.47%-22.1%-15.21%-15.17%-21.2%-21.5%-32.02%-31.16%
Book Value per Share6.5117.6962.57-142.583.9350.2884.57139.36208.19217.97344.93415.32460.92483.80503.15556.74587.04687.05706.04796.75
Total Shareholders' Equity78.11M108.49M15.67M-35.71M1.06M11.74M18.58M30.15M44.93M46.97M74.18M85.08M83.13M86.88M90.2M100.59M104.53M111.53M106.38M118.59M
Common Stock1K1K14K55K54K53K44K44K43K43K43K43K36K36K36K36K36K36K30K30K
Retained Earnings-527.77M-500.03M-424.54M-460.45M-420.99M-407.55M-391.5M-376.47M-364.01M-358.52M-330.79M-319.64M-310.75M-305.4M-300.51M-288.26M-282.73M-274.8M-258.24M-236.6M
Treasury Stock00000000000000000000
Accumulated OCI-17K4.25M4.61M5.75M6.29M6.16M1.96M-35K3.42M1.09M1.82M3.05M516K257K38K-289K-253K-466K-506K-79K
Minority Interest00000000000000000000